Mycodern Spolka Akcyjna Logo

Mycodern Spolka Akcyjna

Producer of functional foods and supplements for manufacturing and distribution.

MCD | WAR

Overview

Corporate Details

ISIN(s):
PLMDNPL00013 (+3 more)
LEI:
25940087YXP4K8ENAO45
Country:
Poland
Address:
GDAŃSK JAŚKOWA DOLINA 132/20, 80-286 GDAŃSK

Description

Mycodern Spolka Akcyjna is a producer of functional foods and innovative dietary supplements. The company's product portfolio includes items such as functional gummies and oils. Its business activities encompass contract manufacturing, wholesale, trading, and retail distribution.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-18 14:14
Podpisanie umowy o sprawowanie nadzoru nad przebiegiem postępowania restruktury…
Polish 1.7 KB
2025-12-16 17:01
zal01_FormularzA_1.pdf
Polish 77.8 KB
2025-12-16 17:01
Zawiadomienie akcjonariusza w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 467 bytes
2025-12-16 09:18
zal01_FormularzA.pdf
Polish 79.4 KB
2025-12-16 09:18
Zawiadomienie akcjonariusza w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 436 bytes
2024-04-08 15:20
Korekta raportu ESPI nr 4/2024 - Zakończenie emisji oraz przydział akcji serii …
Polish 2.1 KB
2024-03-29 20:50
Zakończenie emisji oraz przydział akcji serii E - Content (PL)
Polish 1.5 KB
2024-01-23 23:32
Zawarcie ramowej umowy w zakresie wytwarzania i dostawy żelków - Content (PL)
Polish 1.2 KB
2024-01-23 23:29
Dokument Ofertowy - MCD
Polish 388.9 KB
2024-01-23 23:29
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.2 KB
2024-01-23 17:20
Zawarcie umowy o współpracy - Content (PL)
Polish 1.7 KB
2023-12-31 20:02
zal01_Fundacja-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 183.3 KB
2023-12-31 20:02
zal02_MP-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 181.8 KB
2023-12-31 20:02
Zawiadomienia akcjonariuszy w sprawie zmiany udziału w głosach - Content (PL)
Polish 637 bytes
2023-12-29 22:27
MCD - dokument ofertowy (seria E)
Polish 444.1 KB

Automate Your Workflow. Get a real-time feed of all Mycodern Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mycodern Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mycodern Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DAEWOONG PHARMA Logo
Develops and manufactures drugs, biologics, and active pharmaceutical ingredients.
South Korea
069620
DAIICHI SANKYO COMPANY, LIMITED Logo
A global healthcare company that researches and develops novel pharmaceutical solutions.
Japan
4568
Daito Pharmaceutical Co., Ltd. Logo
Integrated manufacturer of APIs and finished drugs for generic and OTC markets.
Japan
4577
Dare Bioscience, Inc. Logo
A clinical-stage biopharmaceutical company advancing innovative products for women's health.
United States of America
DARE
Day One Biopharmaceuticals, Inc. Logo
Commercial-stage company developing targeted cancer therapies, focusing on pediatrics.
United States of America
DAWN
DBV Technologies Logo
Develops epicutaneous immunotherapy (EPIT) patch technology for food allergies.
France
DBV
DBV Technologies S.A. Logo
A clinical-stage company developing epicutaneous immunotherapy for food allergies.
United States of America
DBVT
D&D Pharmatech Inc. Logo
Clinical-stage biopharma developing GLP-1 therapies for metabolic and neurodegenerative diseases.
South Korea
347850
Dechra Pharmaceuticals PLC Logo
A global specialist in veterinary pharmaceuticals and related products.
United Kingdom
DPH
DELCATH SYSTEMS, INC. Logo
Interventional oncology company treating liver cancers with targeted chemotherapy.
United States of America
DCTH

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.